Petra Tilkin

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis

Wim Robberecht, Tania Aguirre, Ludo Van Den Bosch et al. · Neurology · 1996 · 127 citations

Motor Neuron Disease, Genetics, Genetic Epidemiology +16

The G93C Mutation in Superoxide Dismutase 1

Luc Régal, Ludo Vanopdenbosch, Petra Tilkin et al. · Archives of Neurology · 2006 · 81 citations

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress

Tania Aguirre, Ludo Van Den Bosch, Kaatje Goetschalckx et al. · Annals of Neurology · 1998 · 72 citations · Full text

Inflammation, Amyotrophic Lateral Sclerosis, Sporadic Als +13